Will DNA sequencing soon make personalized medicine mainstream?

The DNA sequencing products market is growing rapidly as genetic testing becomes more affordable and accessible. These products are widely used in precision medicine, oncology, rare disease diagnosis, forensics, and agriculture research.

Key drivers include falling sequencing costs, rising demand for personalized treatment, and advancements in next-generation sequencing (NGS) technologies. Governments and private companies are also investing heavily in genomics research.

Analysts expect strong market growth over the next decade, with North America leading adoption and Asia-Pacific emerging as a fast-growing region.

Do you think DNA sequencing will become a routine part of healthcare for everyone, or remain focused on high-risk and specialized cases?